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Abstract 
Background: Streptococcus suis is a swine pathogen that causes pneumonia, septicemia and meningitis. It is also 
an important zoonotic agent responsible of several outbreaks in China. S. suis strains are classified into 35 serotypes 
based on the composition of their polysaccharide capsule. S. suis serotype 2 causes the majority of severe infections 
in pigs and in human, and can be further subdivided into sequence types (STs) based on multilocus sequence typ‑
ing. The ST1 is associated with highly virulent strains. In North America, the strains most commonly isolated belong 
to ST25 and ST28, which are respectively moderately and weakly virulent in a mouse model. The presence of S. suis 
bioaerosols in the air of swine confinement buildings has been previously demonstrated. The aim of this study was 
to better understand the aerosolization behaviour of S. suis by investigating the preferential aerosolization of vari‑
ous strains of S. suis, belonging to different serotypes or STs, using in‑house developed environmental chamber and 
bubble‑burst nebulizer. qPCR technology was used to analyze the ratio of S. suis strains.
Results: The results suggest that the highly virulent serotype 2 ST1 strains are preferentially aerosolized and that the 
S. suis preferential aerosolization is a strain‑dependent process.
Conclusion: These observations will need to be confirmed using a larger number of strains. This study is a proof of 
concept and increases our knowledge on the potential aerosol transmission of S. suis.
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Background
Streptococcus suis is a swine pathogen that causes 
important economic losses in the swine industry world-
wide. Swine are natural hosts of S. suis, which can be 
isolated from their tonsils and nasal cavities, as well as 
genital and digestive tracts [1, 2]. S. suis causes a wide 
range of illness in swine such as meningitis, septicemia, 
pneumonia, endocarditis and arthritis. It is also known 
as an important zoonotic agent for individuals in close 
contact with pigs or pork by-products [3]. Two serotype 
2 human infection outbreaks occurred in China with 
more than 200 cases declared and 50 deaths reported 
[4]. However, in North America and Europe, human 
S. suis infections are still considered sporadic. Seven 
human deaths related to S. suis infections have been 
described in Canada and the United States since 1991 
[5–11].
Streptococcus suis strains are classified into 35 different 
serotypes on the basis of the antigenicity of their capsu-
lar polysaccharide [12–15]. Amongst these serotypes, 
serotype 2 is the most commonly isolated from diseased 
animals [1, 3, 12, 16, 17]. Multilocus sequence typing 
(MLST) allowed separating the serotype 2 strains into 
16 sequence types (STs) based on genetic variations. The 
ST1 is associated with invasive and highly virulent strains 
[18–20]. In North America, strains belonging to ST25 
and ST28 are most often recovered in infected pigs [21]. 
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They are respectively strains with moderate and weak vir-
ulence in a mouse model [21].
Healthy carrier pigs could act as an infectious reser-
voir for pathogenic strains of S. suis. Many modes of 
transmission have been proposed for the transfer of S. 
suis between swine within the herd. The most accepted 
relates to a transmission of S. suis by a ‘‘nose-to-nose’’ 
contact between uninfected and infected pigs, especially 
when animals show clinical signs of infection [1, 22]. In 
2001, Berthelot-Hérault et  al. [22, 23] first emphasized 
the transmission of S. suis virulent serotype 2 strains 
through aerosols from infected swine to pathogen-free 
swine. Then, Dekker et  al. [24] further supported these 
observations and showed that a clinical serotype 9 strain 
could be transmitted through aerosols. Very recently, 
Bonifait et al. [25] demonstrated the presence of S. suis, 
more particularly serotype 2, in bioaerosols of swine 
confinement buildings (SCBs), with and without recent 
documented infection cases. All the above studies sup-
port the potential of air transmission of this swine and 
zoonotic pathogen.
The notion of preferential aerosolization was intro-
duced by Parker et al. [26] when they showed that Myco-
bacterium intracellulare was more concentrated than 
Mycobacterium scrofulaceum in air samples produced 
by an equally mixed solution using smooth bubble-burst 
nebulizer. Moletta et  al. [27] have also highlighted this 
concept of preferential aerosolization of some microor-
ganisms in anaerobic microbial communities and con-
sequently suggested that aerosolization appears to be a 
non-randomly phenomenon and that some bacteria are 
more prone to be transferred to the air.
The aim of this study was to investigate the aerosoliza-
tion behaviour of S. suis in a controlled environment. In 
this regard, the possibility of a preferential aerosolization 
of different isolates of S. suis has been studied in terms of 
serotype (serotype 2, serotype 5) and of ST (ST1, ST25, 
ST28) in order to determine whether the virulence of the 
strains may be related to their aerosolization.
Methods
Serotype and sequence type (ST)
The serotype 2 S. suis S735 was aerosolized with either 
strain of serotype 5 (Amy12C, 4B) included in this study, 
in order to compare the preferential aerosolization of 
S. suis serotype 2. The choice of serotype 5 strains was 
based on the fact they present differences in morphologi-
cal characteristics. Indeed, S. suis serotype 5 appears to 
possess a capsule thinner than that of S. suis serotype 2 
[28]. Seven strains belonging to either ST1, ST25 or ST28 
was tested (Table 1) [21]. Each strain was nebulized sepa-
rately with S. suis Amy12C (serotype 5) used as an inter-
nal reference strain. Strains of S. suis used in this study 
are listed in Table 1. Bacteria were grown in Todd Hewitt 
Broth (THB) (Difco Laboratories, Becton, Dickinson and 
Company, Sparks, MD, USA.) at 37 °C.
Cell surface hydrophobicity test
Cell surface hydrophobicity was determined by measuring 
the adsorption of S. suis cells to n-hexadecane as described 
previously [29]. Assays were performed in triplicate.
Experimental chamber
The chamber used in this study was designed, built and 
characterized by Perrott et  al. (Manuscript in prepara-
tion). This chamber consists in a stainless steel drum of 
45.2 L, was 470 mm in height by 350 mm in diameter and 
was airtight by a lid (Fig. 1). Ports were created to allow 
nebulization or air sampling.
Preparation of nebulizing solutions
For each comparative analysis, two strains of S. suis were 
grown separately in 300 mL of THB overnight, and har-
vested by centrifugation (10 min at 7000×g). Cells were 
washed twice with 1X Phosphate Buffered Saline (PBS, 
Lonza, Bâle, Switzerland) and suspended in PBS at an 
optical density 660 nm = 1.5 (about 4 × 108 bacteria/mL) 
using a GeneQuant pro spectrometer (model 80-2114-
98, GE Healthcare Biosciences, Buckinghamshire, Eng-
land). Nebulizing solutions of 150 mL were prepared and 
contained both strains of S. suis.
Preferential aerosolization assay
For the preferential aerosolization assays, two different S. 
suis strains were mixed in the nebulizing solution. Ratios 
in the nebulizing solution and in the air were compared 
to evaluate if one of the two strains was enriched in the 
bioaerosols compared with the original bacterial suspen-
sion. Aerosolization assays of tested strains were per-
formed in duplicate.
Table 1 Serotype, sequence type (ST), origin and diseases 
of S. suis strains used in this study
Strain Serotype ST Origin Tissue/disease
P 1/7 2 1 United Kingdom Meningitis
S735 2 1 Netherlands Pneumonia
MGGUS2 2 1 United States Brain
MGGUS4 2 25 United States Septicaemia
MNCM51 2 25 Thailand Septicaemia
MGGUS10 2 28 United States Lung
MGGUS11 2 28 United States Lung
Amy12C 5 NA Canada Infected pig
4B 5 NA Canada Infected pig
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Nebulization
The nebulizer used in this study has been described by 
Perrot et  al. (Manuscript in preparation). Briefly, this 
nebulizer was designed to mimic the bubbling process 
and minimize the stress associated with the aerosoli-
zation of bacteria. Using commercial nebulizer, as jet 
nebulizer, a high-speed airstream hits the liquid bacteria 
suspension and creates cell wall damages [30–32]. The 
bubbling nebulizer was located inside the experimental 
chamber. It was made with a 250  mL of polypropylene 
container to allow sterilization by an autoclave (Fig.  2). 
At the bottom of the container, a hole was made to fix 
a stainless steel tube that allows air to pass. At the end 
of the tube, the air passes through a cotton fabric that 
makes bubbles and creates bioaerosols.
Aerosolization
Aerosolization was performed with a nebulization set at 
4 L/min and an addition of dilution air at 6 L/min. Prior 
to bacterial aerosolization, PBS was aerosolized for con-
ditioning the chamber; this was followed by a purge of 
the chamber prior to the baseline air sampling. Bacte-
ria were first nebulized during 20  min to fill the cham-
ber with aerosols and then, the air of the chamber was 
sampled. Between each duplicate, the nebulizer and the 
nebulizing solution were changed. The temperature and 
relative humidity were monitored using the Omega RH-
USB probe (Omega Engineering, Inc., Stamford, CT). 
Introducing dry air into the chamber controlled the tem-
perature and humidity. The humidity was also controlled 
using silica beads.
Air sampling
Aerosols and baselines were sampled using SKC 37 mm 
cassettes (SKC Inc., Eighty-Four, PA, USA) loaded with 
a 0.8  μm polycarbonate filter (SKC Inc., Eighty-Four, 
PA, U.S.A.). The cassettes were connected to a Gilian 
AirCon2 High Volume Air Sampler (Gilian Instrument 
Corp., W. Caldwell, NJ, USA.) set at 10 L/min, for 30 min. 
Aerosol samples were taken during the nebulization. Fil-
ter samples were eluted in 5  mL of PBS using Genie-2 
vortex (Scientific industries, Bohemia, NY, USA.) for 
15 min. A blank was prepared for each experiment (cas-
settes not plugged to a pump).
DNA extraction
Aliquots of air samples and nebulizing solution (1.5 mL) 
were centrifuged for 10 min at 14,000×g and the pellets 
were stored at −20 °C until use. DNA extraction was per-
formed with MOBio PowerLyser® UltraClean® Microbial 
DNA kit (Carlsbad, CA, USA.) following the manufactur-
er’s instructions using homogenization with Mixer Mill 
MM301 (Retsch, Düsseldorf, Germany) at 20 movements 
per min during 10  min. DNA was eluted with 50 μL of 
elution buffer supplied with the kit. Samples were kept at 
−20 °C.
Quantitative PCR
Quantitative PCR (qPCR) analyses were performed with 
the Bio-Rad CFX 96 Touch™ Real-time PCR Detection 
System (Bio-Rab Laboratories, Mississauga, ON, Can-
ada). Primers and probes were purchased from Integrated 
DNA Technologies (Coralville, IA, USA.) and are listed in 
Table 2. Results were analyzed using the CFX Manager™ 
Software version 3.1 (Bio-Rad Laboratories). Quantifi-
cation of S. suis serotype 2 was performed according to 
Nga et al. [33]. Primers target the cps2J gene that is part 
of the serotype 2 capsular polysaccharide operon [34]. As 
standard curve, a 10-fold dilution of S. suis S735 genomic 
DNA was used. Quantification of S. suis serotype 5 was 
made as previously described by Wang et al. [35]. Prim-
ers target the cps5I gene that is part of the serotype 5 
Fig. 1 Experimental chamber used for the preferential aerosolization 
process
Fig. 2 Smooth bubble‑burst nebulizer used for the preferential 
aerosolization process
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capsular polysaccharide operon coding for a glycosyl-
transferase [35]. As standard curve, a 10-fold dilution of 
S. suis 4B genomic DNA was used.
Results
Temperature and relative humidity
The temperature and the relative humidity inside the 
chamber during the preferential aerosolization assays 
were respectively 22.9 °C and 63.5 %.
Cell surface hydrophobicity
Table  3 reports the relative cell surface hydrophobicity 
for strains of S. suis used in this study. All S. suis sero-
type 2 strains showed a low cell surface hydrophobicity 
(≤11 %) compared to the high hydrophobicity observed 
for the serotype 5 strains (≥87 %).
Preferential aerosolization assay
The ratios of the tested strains of S. suis in the nebuliz-
ing solution and the bioaerosols are reported in Fig.  3. 
A ratio of 100 % means that the tested strain represents 
the entire sample. The serotype 2 strain S. suis S735 was 
aerosolised along with either S. suis Amy12C or S. suis 
4B, two serotype 5 isolates. Figure 3a shows that S. suis 
S735 is preferentially recovered in bioaerosols when 
aerosolized concomitantly with S. suis Amy12C. How-
ever, although the ratio in the air is higher than that in 
the nebulizing solution, these differences are not statisti-
cally significant (p < 0.05). Regarding S. suis 4B, an oppo-
site result was obtained. Indeed, the serotype 5 strain was 
the one almost exclusively detected in the bioaerosols 
(Fig. 3B).
Strains belonging to different STs were aerosolized 
separately with S. suis Amy12C (serotype 5) used as 
Table 2 Primers and probe used in this study
NA Not applicable
Primer/probe Target Sequence Amplicon length (pb) Reference
CpS2Jf cps2J 5′‑GGTTACTTGCTACTTTTGATGGAAATT‑3′ 88 Nga et al. [33]
CpS2Jr cps2J 5′‑CGCACCTCTTTTATCTCTTCCAA‑3′ 88 Nga et al. [33]
CpS2Jp cps2J 5′‑FAM‑TCAAGAATCTGAGCTGCAAAAG
TGTCAAATTGA‑TAMRA‑3′
88 Nga et al. [33]
CpS5If cps5I 5′‑TTTTCGTTGTATTTTCCAAA‑3′ 262 Wang et al. [35]
CpS5Ir cps5I 5′‑TCCAAACATTATCCCCTATT‑3′ 262 Wang et al. [35]
Table 3 Relative cell surface hydrophobicity of  S. suis 
strains used in this study
NA Not applicable
a Two out of three values were negative
b The three values were negative
Serotype ST Strains of S. suis Hydrophobicity (%)
2 1 P1/7 11 ± 5
S735 6 ± 7
MGGUS2 1a
25 MGGUS4 5 ± 2
MNCM51 5 ± 1
28 MGGUS10 >0b
MGGUS11 5 ± 2
5 NA Amy12C 88 ± 7

































































Fig. 3 Comparative analysis of strains belonging to different sero‑
types. a Ratio of S. suis S735 (serotype 2) in the nebulizing solution 
and in the air compared to S. suis Amy12C (serotype 5) and b ratio 
of S. suis S735 (serotype 2) in the nebulizing solution and in the air 
compared to S. suis 4B (serotype 5)
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an internal reference strain. The ST1 virulent strains 
selected were isolated from pigs meningitis/septicemia 
cases [21]. ST25 and ST28 strains were isolated from 
pigs septicemia and pneumonia cases, respectively [21]. 
Figure  4 compares the aerosolization of the S. suis ST1 
(3 strains), ST25 (2 strains) and ST28 (2 strains) when 
pooling data obtained for the different strains. For S. suis 
ST1, the ratio in the nebulizing solution was 53 %, while 
the ratio in the air was 80 % which is statistically differ-
ent (p = 0.0059). The ratio in the nebulizing solution for 
S. suis ST25 was 81 % and its ratio in the air was 57 %. 
Lastly, ratios in the nebulizing solution and in the air for 
the S. suis ST28 were respectively 78 and 75 %. There are 
no statistical differences for the S. suis ST25 and ST28.
Discussion
The presence of S. suis in the air of SCBs and the potential 
risks of transmission of this pathogen through bioaero-
sols have been previously studied [22, 24, 25]. However 
a better understanding of the aerosolization process of 
S. suis is essential and was the topic of this study. More 
specifically, we proposed the hypothesis of a preferential 
aerosolization of S. suis in function of serotype and ST.
Given that S. suis serotype 2 is the serotype most com-
monly isolated from diseased animals, it can be suggested 
that this serotype is preferentially aerosolized compared 
to the others. When comparing the preferential aero-
solization behaviours of S. suis S735 (serotype 2) with S. 
suis Amy12C or S. suis 4B (serotype 5), it appears that 
aerosolization is more likely to be strain-dependent than 
serotype-dependent, although additional strains belong-
ing to different serotypes should be tested. Both strains 
of S. suis serotype 5 possessed characteristics (thin cap-
sule and high hydrophobicity) that differentiate them 
from serotype 2 strains [28]. Consequently, these two 
properties appear not to have significant impact on the 
preferential aerosolization of S. suis.
Preferential aerosolization occurs when the ratio of 
bacteria is higher in the air compared to the original 
source. In this regard, S. suis ST1 strains tested in this 
study, but not S. suis ST25 and ST28 strains, appear to be 
statistically preferentially aerosolized. Differences at the 
gene and protein levels may at least in part, explain the 
aerosolization behaviours of the various ST [36]. Tringe 
et  al. [36] showed that fimbrial adhesin genes are up-
regulated in air. It has been shown that S. suis possesses 
pili that have a putative role as adhesins [16]. The ST1 
strains express the Sfp1 pilus but not the Sgp1 (Sfp1+/
Sgp1−) [21]. It can be suggested that virulence factors 
could be involved in the preferential aerosolization pro-
cess. Suilysin and extracellular factor are two virulence 
factors expressed by ST1 strains and not by ST25 and 
ST28 strains [21, 37]. Ye et  al. demonstrated that the 
ST1 strains evolved from the ST25 strains and that they 
acquired 132 genomic islands, including 5 pathogenic-
ity islands and 4 ST1 specific genes [19]. One or several 
genes acquired by ST1 isolates could favour bacterial 
aerosolization. Very recently, Atanassov et al. [38] identi-
fied nine proteins that differentiate ST1, ST25 and ST28 
from other STs; including two that were overexpressed by 
ST1. These two proteins have not been purified for iden-
tification. Again, these proteins overexpressed by ST1 
could promote the aerosolization of these strains. The 
proteins and genes specific or overexpressed by the ST1 
strains could modify the water/air interface cell affinity or 
change the cell density. These factors could contribute to 
the preferential aerosolization process. The construction 
of mutants deficient in specific factors may allow evaluat-
ing the above hypotheses.
Strains less present in the air could be carried within 
the larger droplets which sediment. The preferentially 
aerosolized strains could be included in the smaller drop-
lets that remained longer in the air and included in the 
air samples. It could explain the difference between air 
ratio of the different strains.
A better understanding of the aerosolization process of 
S. suis is essential to reduce the economic losses for the 
swine industry and to increase the swine’s health. Fur-
thermore, aerosolization studies are of particular interest 
because S. suis is an important zoonotic agent especially 
in the Asian countries where the proximity between 
swine and farmers is more important.
Conclusion
This study is a proof of concept and provides new evi-
dence on the potential risks associated with the trans-
mission of S. suis serotype 2 through bioaerosols. It also 



























* p < 0.05
Fig. 4 Ratio of different ST of S. suis serotype 2 in the nebulizing solu‑
tion and in the air. ST1, 3 strains tested. ST25, 2 strains tested. ST28, 2 
strains tested. A Student’s t test analysis for normal distribution was 
used to perform comparisons. * Significantly different at P value <0.05
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ST1 strains and that preferential aerosolization of S. suis 
is likely a strain-dependent process, although more stains 
should be studied. This study emphases the importance 
to develop an exposure prevention strategy to protect the 
swine and the swine producers against S. suis infections.
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